Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPSIA-STEMI: Prehospital Facilitated PCI vs Primary PCI
NCT00359918Phase 4Completed
- Start
- Aug 2006
- Primary completion
- Aug 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tenecteplase in ST elevation myocardial infarction (STEMI) (2 arms). Primary endpoints: Infarct size assessed by MRI and Microvascular obstruction assessed by MRI. Started Aug 2006; status: completed.
02
Drugs
tenecteplase
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00359918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359918.